— Know what they know.
Not Investment Advice

SGHT NASDAQ

Sight Sciences, Inc.
1W: -1.1% 1M: +20.4% 3M: -4.8% YTD: -31.3% 1Y: +57.2% 3Y: -47.8%
$5.03
-0.11 (-2.14%)
 
Weekly Expected Move ±15.1%
$3 $4 $5 $6 $6
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 70 · $273.7M mcap · 35M float · 0.960% daily turnover · Short 62% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$77M -3.1% ▼
5Y CAGR: +22.9%
Gross Profit
$67M -2.4% ▼
5Y CAGR: +29.3%
Operating Income
-$37M +26.6% ▲
Net Income
-$38M +25.4% ▲
EPS (Diluted)
$-0.74 +28.2% ▲
EBITDA
-$37M +20.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$49M$71M$81M$80M$77M
YoY Growth+77.1%+45.7%+13.6%-1.5%-3.1%
Cost of Revenue$9M$12M$12M$12M$11M
Gross Profit$40M$59M$69M$68M$67M
Gross Margin82.4%82.7%85.3%85.5%86.2%
R&D Expenses$16M$23M$18M$18M$15M
SG&A Expenses$76M$120M$109M$101M$89M
Operating Expenses$92M$143M$126M$119M$104M
Operating Income-$51M-$84M-$57M-$51M-$37M
Operating Margin-105.2%-117.7%-70.7%-63.3%-48.0%
Interest Expense$4M$4M$5M$5M$5M
Income Before Tax-$63M-$86M-$55M-$51M-$38M
Tax Expense$188K$47K$110K$236K$10K
Net Income-$63M-$86M-$56M-$52M-$38M
Net Margin-128.6%-120.9%-68.5%-64.5%-49.7%
EPS (Diluted)$-1.33$-1.80$-1.14$-1.03$-0.74
EBITDA-$57M-$80M-$49M-$46M-$37M
Shares Outstanding48M48M49M50M52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms